Urologe

Public

Metzger, T; Thalmann, G N; Zehnder, P (2012). [Lymphadenectomy for bladder cancer: current status and controversies]. Urologe, 51(3), pp. 310-8. Berlin: Springer-Verlag 10.1007/s00120-012-2833-6

Moltzahn, F; Thalmann, G N (2012). [Bone metastasis in prostate cancer]. Urologe, 51(1), pp. 20-6. Berlin: Springer-Verlag 10.1007/s00120-011-2741-1

Spahn, M; Haeni, K (2012). [Approach to prostate cancer in men older than 75 years: active or passive?]. Urologe, 51(10), pp. 1368-74. Berlin: Springer-Verlag 10.1007/s00120-012-3011-6

Kälble, T; Hofmann, I; Thüroff, J W; Stein, R; Hautmann, R; Riedmiller, H; Vergho, D; Hertle, L; Wülfing, C; Truß, M; Roth, S; von Rundstedt, F C; Albers, P; Gschwend, J; Herkommer, K; Humke, U; Spahn, M; Bader, P; Steffens, J; Harzmann, R; ... (2012). [Secondary malignancies in urinary diversions]. Urologe, 51(4), 500, 502-6. Berlin: Springer 10.1007/s00120-012-2815-8

Spahn, M; Krebs, M (2012). [How should hormone therapy for castration-resistant prostate cancer be continued?]. Urologe, 51(1), pp. 15-19. Berlin: Springer 10.1007/s00120-011-2738-9

Schumacher, Martin; Burkhard, Fiona C.; Studer, Urs E. (2005). The role of pelvine lymphadenectomy in prostate cancer. Urologe, 44(6), pp. 645-651. Springer-Verlag 10.1007/s00120-005-0828-2

Thalmann, George (2012). Advanced prostate cancer. Urologe, 51(1) Springer-Verlag 10.1007/s00120-011-2736-y

Thalmann, George (2007). Projekte des 6. EU-Rahmenprogramms. Urologe, 46(9), pp. 1274-1278. Springer-Verlag 10.1007/s00120-007-1497-0